• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
  

PubMed=3026962; PMCID=PMC1453332
Guy K., Middleton P.G., Docherty L.J.M., De Angelis C.L., Steel C.M.
MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.
Immunology 59:603-610(1986)

PubMed=2298494; DOI=10.1002/ijc.2910450120
Guy K., Middleton P.G., Bansal N.S., Ross J.A., Steel C.M.
Recurrent mutation of immunoglobulin and c-myc genes and differential expression of cell surface antigens occur in variant cell lines derived from a Burkitt lymphoma.
Int. J. Cancer 45:109-118(1990)

PubMed=1339415; DOI=10.1002/ijc.2910520320
Middleton P.G., Miller S., Ross J.A., Steel C.M., Guy K.
Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines.
Int. J. Cancer 52:451-454(1992)

PubMed=20454443; DOI=10.1155/2010/904767; PMCID=PMC2861168
Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.
J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)